Campbell Alliance Trade and Distribution Practice to Speak at CBI’s Specialty Pharmaceuticals, Biotech Therapies and Injectables Conference

January 27, 2009

Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Tony Lanzone, Vice President and head of its Trade and Distribution Practice, will present a session at the Center for Business Intelligence’s (CBI) 6th Annual Specialty Pharmaceuticals, Biotech Therapies and Injectables:  A Forum for Payors.  The conference will be held January 28 and 29, 2009, at the Fiesta Conference Center in Tempe, Arizona.


Mr. Lanzone will present a session at 3:30 pm on the first day of the conference.  His session, titled “Partnering With Specialty Pharmacies,” will examine the current market dynamics for specialty products and offer a framework for partnering more strategically with specialty pharmacies.


The conference, which typically attracts executives from leading health plans, providers, manufacturers, and employers, will feature sessions from industry leaders focused on developing successful strategies for cost control, benefit design, and reimbursement for specialty pharmaceuticals.


“With the rapid growth and changing dynamics of the specialty pharmaceutical market, it is more critical than ever for manufacturers to effectively partner with specialty pharmacies.  In today’s environment, failure to do so can adversely affect the commercial viability of a product,” said Lanzone.  “Manufacturers that market specialty products should take a measured and systematic approach to developing their strategies for working with specialty pharmacies.”


Campbell Alliance’s Trade and Distribution Practice, under Mr. Lanzone’s leadership, helps pharmaceutical and biotech companies develop strategies and address business challenges related to product distribution, improve the effectiveness of trade programs, and more effectively work with retail and specialty pharmacies.


Mr. Lanzone has approximately 20 years of experience in the healthcare industry, ranging from working at a top-five pharmaceutical company to management consulting in both the hospital and pharmaceutical sectors.  Prior to joining Campbell Alliance, he was a consultant in Ernst & Young’s Healthcare Consulting Practice and served as a senior director in Premier’s HealthCare Informatics Division.  Mr. Lanzone earned his MBA from the Mason Graduate School of Business at the College of William & Mary.


For more information on CBI’s 6th Annual Specialty Pharmaceuticals, Biotech Therapies and Injectables: A Forum for Payors, please visit


Executives from Campbell Alliance are invited to speak at many conferences in the US and Europe each year.  For a full listing of events, please refer to the company’s online conference calendar at


About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry.  The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms.  Campbell Alliance is organized into practice areas, each specializing in a critical industry function:  Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution.  From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and London, the firm serves clients throughout North America, Europe, and Japan.  For more information on Campbell Alliance, please visit


inVentiv Health Consulting offers world class healthcare consulting services.

Media Contact:

Stephanie Koenig